Linda Black
CEO at Gallant Therapeutics
Dr Linda Black, DVM, PhD, has been CEO of Gallant Therapeutics since April 2021. With deep experience in veterinary stem cell therapies, she led the development of groundbreaking “off-the-shelf” stem cell treatments for dogs. Linda holds a DVM and a PhD in cell and molecular biology and has completed a post-doctoral fellowship at GlaxoSmithKline.
All articles by Linda Black
Have you heard about our
IVP Membership?
A wide range of veterinary CPD and resources by leading veterinary professionals.
Stress-free CPD tracking and certification, you’ll wonder how you coped without it.
Discover more